Cancer BiologybioRxivPreprint
Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance
M. Maitituoheti, A. Shi, M. Tang…·K. Rai
The paper identifies enhancer-based biomarkers of resistance to anti-PD-1 therapy in melanoma and suggests enhancer blockade combined with ICB as a potential strategy to improve treatment responses.